
Overview
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY.
Dr. Rai is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.
Dr. Rai is board certified in American Board Of Pediatrics. He is actively involved in clinical research, co-authoring 80 peer reviewed articles. Dr. Rai is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
Locations
450 Lakeville Road, Entrance B, Lake Success, NY 11042
Additional Areas of Focus
Dr. Rai has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Kolitz is currently accepting new patients.
Office
Jacqueline Barrientos is a Hematologist practicing medicine in New Hyde Park, New York. Dr. Barrientos is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Splenectomy, and Bone Marrow Aspiration. Dr. Barrientos is currently accepting new patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Richard Carvajal is a Hematologist and an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Carvajal is currently accepting new patients.
Northwell Health Physician Partners Smith Institute For Urology At Lake Success
Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kavoussi is board certified in American Board Of Urology. Dr. Kavoussi is currently accepting new patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Douglas Gladstone is an Oncologist and a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gladstone is currently accepting new patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, and American Board Of Internal Medicine/Hematology. Dr. Seetharamu is currently accepting new patients.
Frequently Asked Questions about Dr. Kanti R. Rai
How do I make an appointment with Dr. Kanti R. Rai?
You can book an appointment with Dr. Kanti R. Rai by calling their office at 516-734-8900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kanti R. Rai a top-rated expert for Chronic B-Cell Leukemia (CBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kanti R. Rai is classified as an Elite expert for Chronic B-Cell Leukemia (CBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kanti R. Rai specialize in?
While Dr. Kanti R. Rai is a Hematology Oncology, they have specific expertise in Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Leukemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Kanti R. Rai participate in research or clinical trials?
Yes. Dr. Kanti R. Rai has published 80 articles and abstracts on conditions like Chronic B-Cell Leukemia (CBCL). You can view a list of Dr. Kanti R. Rai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kanti R. Rai accept my insurance?
Dr. Kanti R. Rai accepts most major insurance plans, including Cigna and Humana. We recommend calling the office directly at 516-734-8900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- LeukemiaDr. Rai isElite. Learn about Leukemia.
- Distinguished
- Hairy Cell Leukemia (HCL)Dr. Rai isDistinguished. Learn about Hairy Cell Leukemia (HCL).
- Richter SyndromeDr. Rai isDistinguished. Learn about Richter Syndrome.
- Small Lymphocytic Lymphoma (SLL)Dr. Rai isDistinguished. Learn about Small Lymphocytic Lymphoma (SLL).
- Advanced
- Febrile NeutropeniaDr. Rai isAdvanced. Learn about Febrile Neutropenia.
- Experienced
- Acute Mountain SicknessDr. Rai isExperienced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Rai isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Rai isExperienced. Learn about Anemia.
- Autoimmune Hemolytic AnemiaDr. Rai isExperienced. Learn about Autoimmune Hemolytic Anemia.
- B-Cell LymphomaDr. Rai isExperienced. Learn about B-Cell Lymphoma.
- Chronic Familial NeutropeniaDr. Rai isExperienced. Learn about Chronic Familial Neutropenia.
- Classical Hodgkin LymphomaDr. Rai isExperienced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- HemochromatosisDr. Rai isExperienced. Learn about Hemochromatosis.
- Hodgkin LymphomaDr. Rai isExperienced. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Rai isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- LeukocytosisDr. Rai isExperienced. Learn about Leukocytosis.
- Mantle Cell Lymphoma (MCL)Dr. Rai isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Mycosis FungoidesDr. Rai isExperienced. Learn about Mycosis Fungoides.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Non-Hodgkin LymphomaDr. Rai isExperienced. Learn about Non-Hodgkin Lymphoma.
- Polycythemia VeraDr. Rai isExperienced. Learn about Polycythemia Vera.




